Press release
Intravenous Immunoglobulin (IVIG) Market: Rising Prevalence of Neurological Diseases to Boost Global Demand for IVIG Products
Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global intravenous immunoglobulin (IVIG) market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.
Browse Market Research Report @ http://www.transparencymarketresearch.com/intravenous-immunoglobulin-market.html
A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also provide insights into the key trends of the intravenous immunoglobulin (IVIG) market such as shift from intravenous to subcutaneous infusion of immunoglobulin.
The key market indicators influencing global intravenous immunoglobulin (IVIG) market taken into consideration include prevalence of immunological disorders, global blood and plasma yield and geriatric population. The report also includes market attractiveness analysis of the major segments that provides a thorough analysis of the overall competitive scenario in the global intravenous immunoglobulin (IVIG) market. The report also highlights key events of the global intravenous immunoglobulin industry. A value chain analysis along with list of major players, hospitals and distributors is also included in the report.
Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. The year on year growth of global intravenous immunoglobulin (IVIG) market for each segment is also reflected. Additionally, market related factors such as increasing preference for product innovation, and growing number of acute and chronic patients in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.
Based on indication, the global intravenous immunoglobulin (IVIG) market has been segmented into chronic inflammatory demyelinating polyneuropathy (CIDP), primary humoral immunodeficiency, idiopathic thrombocytopenic purpura (ITP), Guillain-Barre syndrome, myasthenia gravis, multifocal motor neuropathy (MMN), Kawasaki disease, hypogammaglobulinemia, chronic lymphocytic leukemia, and others. Based on end-user, the market has been segmented into hospitals, clinics, and home care. Hospitals segment is expected to remain dominant during the forecast period. However, home care segment is expected to grow at a higher CAGR than others.
For more information on this report, fill the form @ http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1930
Geographically, the global intravenous immunoglobulin (IVIG) market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the regions have been further segmented into major countries from each region. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Australia, India, Japan, Brazil, and Mexico.
The report also profiles major players in the intravenous immunoglobulin (IVIG) market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. A thorough market share analysis of major companies operating in the intravenous immunoglobulin (IVIG) market is provided in the report.
The report also includes a competition matrix that provides insights into recent developments and activities done by the major market players. Key companies profiled in the report include Baxalta Incorporated, Biotest AG, China Biologic Products, Inc., CSL Behring LLC, Grifols S.A., Kedrion S.p.A., LFB Biomedicaments S.A., Octapharma AG, and Sanquin Plasma Products B.V.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Intravenous Immunoglobulin (IVIG) Market: Rising Prevalence of Neurological Diseases to Boost Global Demand for IVIG Products here
News-ID: 529674 • Views: …
More Releases from Transparency Market Research
Automotive Camera Market Outlook 2031: Global Industry Set to Expand from US$ 13 …
The global automotive camera market is undergoing rapid transformation as vehicles evolve from purely mechanical machines into intelligent, sensor-driven mobility platforms. Valued at US$ 13.8 billion in 2022, the market is estimated to grow at a compound annual growth rate (CAGR) of 10.0% from 2023 to 2031, reaching US$ 31.9 billion by the end of 2031. This robust growth reflects the accelerating adoption of advanced driver assistance systems (ADAS), rising…
FPSO Market Projected to Reach USD 141,198.0 Billion by 2031, Supported by Risin …
The FPSO Market (Floating Production, Storage, and Offloading) plays a critical role in the global offshore oil and gas industry, enabling efficient hydrocarbon production in deepwater and ultra-deepwater fields. FPSOs are ship-shaped floating facilities used for the processing, storage, and offloading of oil and gas extracted from subsea wells. As offshore exploration moves into deeper and more complex waters, FPSOs have become a preferred solution due to their flexibility, cost…
North America Leads Global Biomarkers Market as Demand for Early Disease Detecti …
The global biomarkers market was valued at US$ 51.2 Billion in 2022 and is projected to expand at a robust CAGR of 10.4% from 2023 to 2031, reaching more than US$ 125.6 Billion by the end of 2031. This strong growth trajectory is driven by the rising prevalence of chronic diseases, increasing adoption of personalized medicine, rapid technological advancements in diagnostics, and expanding applications of biomarkers across healthcare and life…
Non-Small Cell Lung Cancer Therapeutics Market Expanding at 9.4% CAGR Through 20 …
The global Non-Small Cell Lung Cancer (NSCLC) therapeutics market was valued at US$ 28.1 Bn in 2025 and is projected to reach US$ 75.5 Bn by 2036, expanding at a robust compound annual growth rate (CAGR) of 9.4% during the forecast period from 2026 to 2036.
Examine key highlights and takeaways from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=504
This strong growth trajectory reflects the increasing global burden of lung cancer, the rapid…
More Releases for IVIG
IVIg Powder Market 2022-2028 Global Key Manufacturers' Analysis Review
The "Global IVIg Powder Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the IVIg Powder market with detailed market segmentation by drug class and distribution channel. The report provides key statistics on the market status of the leading IVIg Powder market players and offers key trends…
Intravenous Immunoglobulin (IVIG) Market Size, Share | Industry Report 2026
The global Intravenous Immunoglobulin Market was valued at $13.7Billion in 2018 and is forecast to grow at a modestxx.3 % CAGR between 2018 and 2026, culminating in 2026 global sales of $16.7Billion.
Intravenous Immunoglobulin (IVIG) is a solution of highly purified immunoglobulin G, derived from large human plasma that contains antibodies against a broad spectrum of bacterial and viral agents. Intravenous immunoglobulin of properties isa composition that addition of albumin,…
Intravenous Immunoglobulin (IVIG) Market: Rising Production of IVIG Products are …
The global market for intravenous immunoglobulin (IVIG) products and therapies is heading in a positive direction due to several innovative techniques and advantages it offers to clinicians worldwide. The market is expected to expand at a healthy pace in the near future. Factors that will support market’s growth include technological improvements in the methods used for production and purification of IVIG products and an improving health care infrastructure across the…
Global Intravenous Immunoglobulin (IVIg) Market
The Intravenous Immunoglobulin Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The term “immunoglobulin” refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted from…
Global Intravenous Immunoglobulin (IVIG) Market: Rising Patient Pool of Neurolog …
The global intravenous immunoglobulin (IVIG) market is largely consolidated, with top four players: Grifols S.A., CSL Behring LLC, Baxalta Incorporated, and Octapharma AG, accounting for over 70% of the overall market in 2015. Grifols S.A. accounted for the dominant share of 23.0%, chiefly on account of the company’s strong geographic penetration.
Oligopoly in the market has led to intense competition among top players and has compelled companies to take course of…
Global Intravenous Immunoglobulin (IVIg) Market Research Report 2016
This report studies Intravenous Immunoglobulin (IVIg) in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
Pfizer (US)
Baxter International, Inc. (US)
Bharat Serums and Vaccines Limited (India)
Biotest AG (Germany)
China Biologic Products, Inc (China)
Guizhou Taibang Biological Products Co., Ltd (China)
CSL Limited (Australia)
CSL Behring LLC (US)
Grifols, S.A (Spain)
Hualan Biological Engineering Inc. (China)
Kedrion…
